Tranexamic acid (TXA) is an antifibrinolytic agent that inhibits clot breakdown and is well described in the literature toreduce intraoperative blood loss in craniofacial, cardiac, trauma, dermatologic, and orthopedic surgeries.

Tranexamic acid (TXA) is an antifibrinolytic agent that inhibits clot breakdown and is well described in the literature toreduce intraoperative blood loss in craniofacial, cardiac, trauma, dermatologic, and orthopedic surgeries.
The most commonly used adjunctive measures are drain placement, application of tissue sealant, and use of compression dressings
Common measures for minimizing risk include drain placement, application of tissue sealant and use of compression dressings